Li Fei, Tang Rong, Chen Ling-Bo, Zhang Ke-Sheng, Huang Xiao-Ping, Deng Chang-Qing
Molecular Pathology Laboratory, Hunan University of Chinese Medicine.
Hunan Provincial Key Laboratory for Prevention and Treatment of Integrated Traditional Chinese and Western Medicine on Cardio-Cerebral Diseases, Hunan University of Chinese Medicine.
Biol Pharm Bull. 2017;40(5):598-609. doi: 10.1248/bpb.b16-00802.
Danggui Buxue Tang (DBT), a combination of Astragalus and Angelica at a 5 : 1 ratio, mainly promotes hematopoiesis. However, in the clinic, the combination ratio of Astragalus and Angelica to treat low hematopoietic function is not an absolute 5 : 1 ratio, suggesting that the herbs may promote hematopoiesis better after being combined at a certain range of ratios. The objective of this study is to investigate the effect of different ratio combinations of Astragalus and Angelica on bone marrow hematopoiesis suppression induced by cyclophosphamide (CTX) and to probe the interaction and mechanism of Astragalus combined with Angelica in promoting hematopoiesis. Following establishment of the model, mice were administered with Astragalus (6.00 g·kg), Angelica (3.00 g·kg), and combinations of Astragalus and Angelica at different ratios, including 10 : 1 (Astragalus 9.81 g·kg+Angelica 0.98 g·kg), 5 : 1 (Astragalus 9.00 g·kg+Angelica 1.80 g·kg), 2 : 1 (Astragalus 7.71 g·kg+Angelica 3.08 g·kg), 1 : 1 (Astragalus 5.40 g·kg+Angelica 5.40 g·kg), 1 : 2.5 (Astragalus 3.08 g·kg+Angelica 7.71 g·kg), 1 : 5 (Astragalus 1.80 g·kg+Angelica 9.00 g·kg), and 1 : 10 (Astragalus 0.98 g·kg+Angelica 9.81 g·kg). Our results suggested that Astragalus mixed with Angelica synergistically promoted hematopoiesis best when the combination ratio of Astragalus and Angelica was 1 : 1, 1 : 2.5 or 1 : 5; moreover, the effect of Angelica was greater than that of Astragalus. The potential mechanisms of the combinations of Astragalus and Angelica that promote hematopoiesis include the dissolution of the effective components, promoting the synthesis and secretion of hematopoietic growth factor (HGF) and the proliferation of hematopoietic progenitor cells (HPCs).
当归补血汤(DBT)由黄芪和当归按5:1的比例组成,主要促进造血功能。然而,在临床上,黄芪和当归治疗低造血功能的组合比例并非绝对的5:1,这表明在一定比例范围内组合后,这些草药可能更有效地促进造血。本研究的目的是探讨黄芪和当归不同比例组合对环磷酰胺(CTX)诱导的骨髓造血抑制的影响,并探究黄芪与当归联合促进造血的相互作用及机制。模型建立后,给小鼠分别灌胃黄芪(6.00 g·kg)、当归(3.00 g·kg)以及黄芪与当归的不同比例组合,包括10:1(黄芪9.81 g·kg + 当归0.98 g·kg)、5:1(黄芪9.00 g·kg + 当归1.80 g·kg)、2:1(黄芪7.71 g·kg + 当归3.08 g·kg)、1:1(黄芪5.40 g·kg + 当归5.40 g·kg)、1:2.5(黄芪3.08 g·kg + 当归7.71 g·kg)、1:5(黄芪1.80 g·kg + 当归9.00 g·kg)和1:10(黄芪0.98 g·kg + 当归9.81 g·kg)。我们的结果表明,当黄芪与当归的组合比例为1:1、1:2.5或1:5时,黄芪与当归协同促进造血的效果最佳;此外,当归的作用大于黄芪。黄芪与当归组合促进造血的潜在机制包括有效成分的溶解、促进造血生长因子(HGF)的合成与分泌以及造血祖细胞(HPCs)的增殖。